Development of Maternal Antibodies Post ZIKV in Pregnancy is Associated with Lower Risk of Microcephaly and Structural Brain Abnormalities in Exposed Infants
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf146 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Karin Nielsen-Saines und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Zika Virus Infection, Microcephaly, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, Brazilian National Council for Scientific.
Abstract (Originalsprache)
Background
We investigated the association between maternal neutralizing antibodies (nAb) to Zika virus (ZIKV) in pregnancy and neonatal outcomes.
Methods
In pregnant participants with confirmed ZIKV infection, we determined trimester of infection, collected sera longitudinally, and measured nAbs via plaque reduction. In neonates, adverse outcomes included microcephaly (MC), structural brain abnormalities (SBA), hearing, and eye abnormalities. Associations between trimester of infection, nAbs, and neonatal outcomes were analyzed with Cox regression.
Results
In total, 137 ZIKV-positive pregnant participants had neutralization assays performed during pregnancy and postdelivery. Infection rates were 29% in the first, 50% in the second, and 21% in the third trimester. Mean ZIKV nAb titer >2 weeks postinfection was 64 258 (SD 213 288). Ten percent of 90% plaque reduction neutralization assays (PRNT90) titers were <500, 10% 500–1000, 73% > 1000, and 7% did not have serologic follow-up; 15%. of infants had adverse findings. Protective factors against MC in 88 mothers with nAb titers available during pregnancy included infection later in gestation (adjusted hazard ratio [aHR], 0.06; P = .036) and adequate nAb titers (aHR, 0.17; P = .014). No SBA was associated with later infection in pregnancy (aHR, 0.16; P = .017) and adequate nAb titers (aHR, 0.34; P = .012). Adjusting for trimester, higher maternal nAb titers were associated with lower risk of MC and SBA. Seven of 137 participants (5.1%) had positive serum ZIKV polymerase chain reaction (PCR) results beyond 14 days (range, 35–269 days). Participants with ZIKV PCR positivity >60 days (n = 2) had infants with MC/SBA.
Conclusions
MC and SBA were less frequent in infants of mothers with higher ZIKV nAb titers during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, California, USA.
- Institute of Technology on Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
- Acute Febrile Illness Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
- Institute of the Environment and Sustainability, University of California Los Angeles, Los Angeles, California, USA.
- Fernandes Figueira National Institute of Women's, Children's, and Adolescents' Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
ORCID-Profile: Karin Nielsen-Saines, Tahmineh Kalbasi-Romero, Stephanie Almeida da Silva, Tara Kerin, Trevon Fuller, Zilton Vasconcelos, Myung Shin-Sim, Patricia Brasil
Förderung
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
- Brazilian National Council for Scientific
- NEI NIH HHS
- Carlos Chagas Filho Foundation for the Advancement of Science in the State of Rio de Janeiro
- and Technological Development
- National Eye Institute
Zitieren
APA
Nielsen-Saines, K., Kalbasi-Romero, T., Duarte, A. C. M., Almeida da Silva, S., Adachi, K., Damasceno, L., Kerin, T., Fuller, T., Deville, J. G., Moreira, M. E., Vasconcelos, Z., Zin, A., Shin-Sim, M., Barbosa de Lima, S. M., & Brasil, P. (2025). Development of Maternal Antibodies Post ZIKV in Pregnancy is Associated with Lower Risk of Microcephaly and Structural Brain Abnormalities in Exposed Infants. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf146
Vancouver
Nielsen-Saines K, Kalbasi-Romero T, Duarte ACM, Almeida da Silva S, Adachi K, Damasceno L, et al. Development of Maternal Antibodies Post ZIKV in Pregnancy is Associated with Lower Risk of Microcephaly and Structural Brain Abnormalities in Exposed Infants. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf146
BibTeX
@article{NielsenSaines2025,
author = {Nielsen-Saines, Karin and Kalbasi-Romero, Tahmineh and Duarte, Ana Claudia Machado and Almeida da Silva, Stephanie and Adachi, Kristina and Damasceno, Luana and Kerin, Tara and Fuller, Trevon and Deville, Jaime G and Moreira, Maria Elisabeth and Vasconcelos, Zilton and Zin, Andrea and Shin-Sim, Myung and Barbosa de Lima, Sheila Maria and Brasil, Patricia},
title = {Development of Maternal Antibodies Post ZIKV in Pregnancy is Associated with Lower Risk of Microcephaly and Structural Brain Abnormalities in Exposed Infants},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf146}
}
EUVIMED